Detailed molecular and clinical characterization of three patients with 21q deletions.

Clin Genet

Department of Molecular Medicine and Surgery, Clinical Genetics Unit, Karolinska Institutet, Stockholm, Sweden.

Published: February 2010

We have investigated three patients with 21q deletions, two with developmental delay, dysmorphic features and internal organ malformations, and one with cognitive function within the normal range but with some deficits in gross and fine motor development. All aberrations were characterized by array-comparative genomic hybridization (array-CGH). In addition, extensive fluorescence in situ hybridization (FISH) mapping on metaphase chromosomes and mechanically stretched chromosomes was performed on patient 1 who had an extremely complex intrachromosomal rearrangement with 16 breakpoints, four deletions and four duplications. Patients 2 and 3 had interstitial deletions comprising 21q21.1-21q22.11 and 21q11.2-21q21.3, respectively. Partial deletions of 21q are rare and these patients display a highly variable phenotype depending on the size and position of the deletion. A review of the literature identified 38 cases with pure 21q deletions. Twenty-three of these had reliable mapping data. The combined information of present and previous cases suggests that the ITSN1 gene is involved in severe mental retardation in patients with 21q deletion. In addition, a critical region of 0.56 Mb containing four genes, KCNE1, DSCR1, CLIC6 and RUNX1, is associated with severe congenital heart defects, and deletions of the most proximal 15-17 Mb of 21q is associated with mild or no cognitive impairment, but may lead to problems with balance and motor function.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0004.2009.01289.xDOI Listing

Publication Analysis

Top Keywords

patients 21q
12
21q deletions
12
three patients
8
deletions
7
21q
6
patients
5
detailed molecular
4
molecular clinical
4
clinical characterization
4
characterization three
4

Similar Publications

Objective: To illustrate patterns of cytogenetic abnormalities that promote progression and/or transformation in myelodysplastic syndrome.

Methods: In this study we evaluated three different data sets to identify recurrent cytogenetic abnormalities (RCAs) to delineate the cytogenetic evolutionary trajectories and their clinical significance.

Results: Datasets 1 and 2 were 2402 cross sectional samples from Mitelman database of Chromosome Aberrations and Gene Fusions in Cancer; these were used to discover RCAs and to validate them.

View Article and Find Full Text PDF

Non-small cell lung cancer (NSCLC) leads as a primary cause of cancer-related premature mortality in Western populations. This study leverages cutting-edge gene-expression-profiling technologies to perform an in-depth molecular characterization of NSCLC specimens, with the objective of uncovering tumor-specific genomic alterations. By employing DNA microarray analysis, our research aims to refine the classification of NSCLC for early detection, guide molecular-targeted treatment approaches, enhance prognostication, and broaden the scientific understanding of the disease's biology.

View Article and Find Full Text PDF
Article Synopsis
  • A study examined how molecular features, clinical metrics, and treatment affect the overall survival of glioma patients amidst recent changes in classification and care standards.
  • The research involved analyzing 4,400 gliomas from various sources, finding that 27.2% had updated molecular classifications that differed from their initial diagnoses; survival rates varied significantly between different patient groups.
  • The study identified key prognostic factors for different glioma types and created survival prediction tools based on age, molecular features, and treatment, aiming to enhance understanding and research on gliomas.
View Article and Find Full Text PDF
Article Synopsis
  • Somatic copy number alterations (SCNAs), especially arm-level SCNAs, are linked to cancer growth and resistance to treatment, but their role in triple-negative breast cancer (TNBC) is not well understood.
  • In this study, researchers found that certain arm-level SCNAs, like gains at 21q and 7p, are connected to poorer survival rates in TNBC patients, with the gene RIPK4 on 21q being particularly significant.
  • Targeting RIPK4 in experiments showed promise, as it reduced tumor growth and improved survival by enhancing immune cell infiltration, suggesting RIPK4 could be a key factor in TNBC progression and its ability to spread.
View Article and Find Full Text PDF

Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).

Cancer Genomics Proteomics

December 2023

Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

Background/aim: Mixed phenotype acute leukemia (MPAL) is a rare hematologic malignancy in which the leukemic cells cannot be assigned to any specific lineage. The lack of well-defined, pathogenetically relevant diagnostic criteria makes the clinical handling of MPAL patients challenging. We herein report the genetic findings in bone marrow cells from two pediatric MPAL patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!